Other languages I-Mab Börse Stuttgart

Equities

0VY

US44975P1030

Market Closed - Börse Stuttgart Other stock markets 02:06:56 2024-07-03 am EDT			5-day change	1st Jan Change
1.45 ^EUR	-2.68%		-6.29%	-8.59%

Jun. 06	I-Mab Appoints Phillip Dennis as Chief Medical Officer	CI
Jun. 05	I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

I-Mab Appoints Phillip Dennis as Chief Medical Officer	Jun. 06
I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	Jun. 05
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	Jun. 05
I-Mab Announces Chief Medical Officer Changes	Apr. 15
I-mab Biopharma Co., Ltd. completed the acquisition of I-Mab Biopharma Co., Ltd. from I-Mab.	Apr. 01
I-Mab Announces Executive Resignation	Apr. 01
I-Mab Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials	Feb. 15
Biotech firm I-Mab to divest China operations, shift focus to US	Feb. 07
Biotech firm I-Mab to divest China operations	Feb. 07
I-Mab Announces Board Changes , Effective February 10, 2024	Feb. 07
Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading	Jan. 11
I-Mab Says FDA Grants Breakthrough Therapy Designation for Felzartamab to Treat Kidney Disease	Nov. 02
I-Mab and Hi-Bio Announces That the U.S. Food and Drug Administration Has Granted Breakthrough Therapy Designation for Felzartamab, an Investigational Cd38 Antibody, for the Treatment of Primary Memorbranous Nephropathy	Nov. 02
I-Mab Announces Phase 1 Data of Givastomig at Esmo 2023	23-10-16
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1Bb Bispecific Antibody Tj-L14b Abl503	23-10-10
I-Mab Regains Global Rights to Lemzoparlimab	23-09-22
Sector Update: Health Care Stocks Edge Higher Premarket Thursday	23-08-31
Sector Update: Health Care	23-08-31
Salesforce Earnings, Inflation Outlook Bolster Exchange-Traded Funds, Equity Futures Premarket Thursday	23-08-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages I-Mab Börse Stuttgart

Equities

0VY

US44975P1030

Other languages

Filters